Enveric Biosciences Files 8-K
Ticker: ENVB · Form: 8-K · Filed: Sep 2, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, corporate-events
TL;DR
Enveric Biosciences filed an 8-K on Sept 2, 2025, covering disclosures and exhibits.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on September 2, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located at 245 First Street, Riverview II, 18th Floor, Cambridge, MA, 02142.
Why It Matters
This 8-K filing provides updates on Enveric Biosciences' corporate activities and financial reporting, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting various corporate events and disclosures, not indicating any immediate significant financial or operational changes.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- 0000890821 (company) — Central Index Key
- 954484725 (company) — EIN
- 245 First Street, Riverview II, 18th Floor Cambridge, MA, 02142 (company) — Principal executive offices address
- AMERI Holdings, Inc. (company) — Former company name
- SPATIALIZER AUDIO LABORATORIES INC (company) — Former company name
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 2, 2025.
What is Enveric Biosciences, Inc.'s state of incorporation?
Enveric Biosciences, Inc. is incorporated in Delaware.
What is the Commission File Number for Enveric Biosciences, Inc.?
The Commission File Number is 001-38286.
What is the business address of Enveric Biosciences, Inc.?
The business address is 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What are the main items reported in this 8-K filing?
This 8-K filing reports on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2025-09-02 08:30:26
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001641172-25-026143.txt ( ) — 223KB
- envb-20250902.xsd (EX-101.SCH) — 3KB
- envb-20250902_lab.xml (EX-101.LAB) — 33KB
- envb-20250902_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 2, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer